DB01079 and other serotonergic agents : what is the evidence ? Through effects on gastrointestinal motor and secretory function as well as visceral sensation , serotonin ( 5-HT ) plays a key role in the pathogenesis of irritable bowel syndrome ( IBS ) . In particular , 5- Q9H205 and Q13639 receptors appear to be very important in IBS . This article critically appraises the evidence supporting the use of the 5- Q9H205 receptor antagonist alosetron in the treatment of women with diarrhea-predominant IBS . The safety profile and restricted-use program for alosetron is also reviewed . This discussion is followed by a comprehensive review of the efficacy and safety data in support of tegaserod for women with constipation-predominant IBS .